Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in BRTX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | JANE STREET GROUP, LLC | 804K | $302K | β | 3.325% | 0.00% |
| 2 | XTX Topco Ltd | 287K | $108K | β | 1.186% | 0.00% |
| 3 | CITADEL ADVISORS LLC | 273K | $103K | +14.5% | 1.131% | 0.00% |
| 4 | VANGUARD FIDUCIARY TRUST CO | 181K | $68K | +359.6% | 0.750% | 0.00% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 152K | $57K | -31.7% | 0.631% | 0.00% |
| 6 | CITIGROUP INC | 64K | $24K | β | 0.264% | 0.00% |
| 7 | WEALTH ALLIANCE, LLC | 40K | $15K | 0.0% | 0.166% | 0.00% |
| 8 | STATE STREET CORP | 32K | $12K | 0.0% | 0.134% | 0.00% |
| 9 | Keystone Financial Group | 29K | $11K | β | 0.118% | 0.00% |
| 10 | NORTHERN TRUST CORP | 24K | $9K | β | 0.099% | 0.00% |
| 11 | Creative Planning | 22K | $8K | β | 0.090% | 0.00% |
| 12 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16K | $6K | β | 0.067% | 0.00% |
| 13 | StoneX Group Inc. | 14K | $5K | β | 0.057% | 0.00% |
| 14 | VANGUARD CAPITAL MANAGEMENT LLC | 13K | $5K | β | 0.054% | 0.00% |
| 15 | OSAIC HOLDINGS, INC. | 2K | $760 | 0.0% | 0.008% | 0.00% |
| 16 | Tower Research Capital LLC (TRC) | 1K | $550 | +0.1% | 0.006% | 0.00% |
| 17 | HRT FINANCIAL LP | 711K | $267 | β | 2.941% | 0.00% |
| 18 | SBI Securities Co., Ltd. | 699 | $263 | +251.3% | 0.003% | 0.00% |
| 19 | Cornerstone Planning Group LLC | 11 | $3 | 0.0% | 0.000% | 0.00% |
| 20 | TD Waterhouse Canada Inc. | 3 | $1 | 0.0% | 0.000% | 0.00% |
| 21 | UBS Group AG | 1 | $0 | -100.0% | 0.000% | 0.00% |
| 22 | Parallel Advisors, LLC | 1 | $0 | 0.0% | 0.000% | 0.00% |
| 23 | Caitong International Asset Management Co., Ltd | 1 | $0 | 0.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in BRTX β a direct measure of their conviction.
Filings activity in BRTX during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 23 | +64% | 11.03% | +7.21 pp | $1M | +299% |
| Q1 2026 | 14 | 6.7% | 3.82% | +0.68 pp | $0M | 44% |
| Q4 2025 | 15 | 12% | 3.14% | 80.14 pp | $0M | 36% |
| Q3 2025 | 17 | 11% | 83.28% | +55.26 pp | $1M | +31% |
| Q2 2025 | 19 | +5.6% | 28.02% | 3.78 pp | $0M | 3.3% |
| Q1 2025 | 18 | +0.0% | 31.80% | +0.03 pp | $0M | +23% |
| Q4 2024 | 18 | +0.0% | 31.77% | +1.34 pp | $0M | 13% |
| Q3 2024 | 18 | β | 30.43% | β | $0M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying BRTX stock.
Based on Q2 2026 13F filings, institutional ownership of BioRestorative Therapies, Inc. stands at 11.0%, held across 23 reporting institutions.
JANE STREET GROUP, LLC is the largest reported institutional holder of BRTX, with approximately 803,513 shares worth $0.00B as of Q2 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of BRTX, including JANE STREET GROUP, LLC, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP.
Our composite Smart Money Score for BRTX is 83 out of 100 (Strong Smart Money). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
9 institutions opened new positions in BRTX during Q2 2026, while 1 fully exited. 7 added to existing positions and 1 trimmed.
BRTX institutional ownership rose by 7.21 percentage points quarter-over-quarter, with a net change of +9 holders.
The top 10 institutions account for 96.4% of all reported 13F value in BRTX, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
BioRestorative Therapies, Inc. (BRTX) Institutional Ownership